Watson Plans Q4 2010 Ella(R) (ulipristal Acetate) Emergency Contraceptive Launch

Watson Pharmaceuticals, Inc.(NYSE: WPI), announced that it intends to launch ella(R) (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson’s announcement follows the approval of ella(R) by the FDA as safe and effective in preventing unintended for up to 120 hours - or five days - post-unprotected intercourse (UPI) or contraceptive failure…


Read more

Related posts

Leave a Reply